title: Tegaserod in the treatment of constipation-predominant irritable bowel syndrome. Do the risks outweigh the benefits?
authors.forename: Peter
authors.initials: P
authors.lastname: Wood
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced; D003248:Constipation / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D043183:Irritable Bowel Syndrome / Q000188:drug therapy*; D010974:Platelet Aggregation / Q000187:drug effects; D018570:Risk Assessment; D017366:Serotonin Receptor Agonists / Q000009:adverse effects*
chemical_list: D005765:Gastrointestinal Agents; D007211:Indoles; D017366:Serotonin Receptor Agonists; C105050:tegaserod